{ "cik": 1386570, "cik_padded": "0001386570", "entityName": "Niagen Bioscience, Inc.", "fiscal_years": [ { "accn": "0001386570-26-000013", "filed": "2026-03-04", "fiscal_year": 2025, "form": "10-K", "fundamental_units": { "buybacks": "USD", "cost_of_revenue": "USD", "eps_diluted": "USD/shares", "gross_profit": "USD", "net_income": "USD", "operating_cash_flow": "USD", "operating_income": "USD", "revenue": "USD", "stockholders_equity": "USD", "total_assets": "USD", "total_liabilities": "USD" }, "fundamentals": { "buybacks": 251000.0, "cost_of_revenue": 46234000.0, "eps_diluted": 0.2, "gross_profit": 83189000.0, "net_income": 17382000.0, "operating_cash_flow": 13504000.0, "operating_income": 16279000.0, "revenue": 129423000.0, "stockholders_equity": 76533000.0, "total_assets": 106406000.0, "total_liabilities": 29873000.0 }, "period_end": "2025-12-31", "ratio_units": { "gross_margin": "ratio", "leverage": "ratio", "net_margin": "ratio", "operating_margin": "ratio", "revenue_growth_yoy": "ratio", "roa_avg2y": "ratio", "roa_period_end": "ratio", "roe_avg2y": "ratio", "roe_period_end": "ratio" }, "ratios": { "gross_margin": 0.6427682869350888, "leverage": 0.39032835508865454, "net_margin": 0.1343037945342018, "operating_margin": 0.12578135261893172, "revenue_growth_yoy": 0.29946685141118706, "roa_avg2y": 0.19901078518925602, "roa_period_end": 0.16335544988064585, "roe_avg2y": 0.2834938471951528, "roe_period_end": 0.22711771392732547 } }, { "accn": "0001386570-26-000013", "filed": "2026-03-04", "fiscal_year": 2024, "form": "10-K", "fundamental_units": { "buybacks": "USD", "cash": "USD", "cost_of_revenue": "USD", "eps_diluted": "USD/shares", "gross_profit": "USD", "net_income": "USD", "operating_cash_flow": "USD", "operating_income": "USD", "revenue": "USD", "stockholders_equity": "USD", "total_assets": "USD", "total_liabilities": "USD" }, "fundamentals": { "buybacks": 0.0, "cash": 44500000.0, "cost_of_revenue": 38011000.0, "eps_diluted": 0.11, "gross_profit": 61586000.0, "net_income": 8550000.0, "operating_cash_flow": 12109000.0, "operating_income": 7726000.0, "revenue": 99597000.0, "stockholders_equity": 46094000.0, "total_assets": 68278000.0, "total_liabilities": 22184000.0 }, "period_end": "2024-12-31", "ratio_units": { "gross_margin": "ratio", "leverage": "ratio", "net_margin": "ratio", "operating_margin": "ratio", "revenue_growth_yoy": "ratio", "roa_avg2y": "ratio", "roa_period_end": "ratio", "roe_avg2y": "ratio", "roe_period_end": "ratio" }, "ratios": { "gross_margin": 0.618351958392321, "leverage": 0.48127738968195427, "net_margin": 0.08584595921563903, "operating_margin": 0.07757261764912597, "revenue_growth_yoy": 0.1917793466554984, "roa_avg2y": 0.13875139968517225, "roa_period_end": 0.12522335159202086, "roe_avg2y": 0.22937625754527163, "roe_period_end": 0.18549051937345426 } }, { "accn": "0001628280-25-009774", "filed": "2026-03-04", "fiscal_year": 2023, "form": "10-K", "fundamental_units": { "cash": "USD", "cost_of_revenue": "USD", "eps_diluted": "USD/shares", "gross_profit": "USD", "net_income": "USD", "operating_cash_flow": "USD", "operating_income": "USD", "revenue": "USD", "stockholders_equity": "USD", "total_assets": "USD", "total_liabilities": "USD" }, "fundamentals": { "cash": 27200000.0, "cost_of_revenue": 32790000.0, "eps_diluted": -0.07, "gross_profit": 50780000.0, "net_income": -4938000.0, "operating_cash_flow": 7117000.0, "operating_income": -5599000.0, "revenue": 83570000.0, "stockholders_equity": 28456000.0, "total_assets": 54964000.0, "total_liabilities": 26508000.0 }, "period_end": "2023-12-31", "ratio_units": { "gross_margin": "ratio", "leverage": "ratio", "net_margin": "ratio", "operating_margin": "ratio", "revenue_growth_yoy": "ratio", "roa_avg2y": "ratio", "roa_period_end": "ratio", "roe_avg2y": "ratio", "roe_period_end": "ratio" }, "ratios": { "gross_margin": 0.6076343185353595, "leverage": 0.9315434354793365, "net_margin": -0.059088189541701565, "operating_margin": -0.06699772645686251, "revenue_growth_yoy": 0.1598889659958362, "roa_avg2y": -0.09058805184322287, "roa_period_end": -0.08984062295320573, "roe_avg2y": -0.17287494748634644, "roe_period_end": -0.17353106550463873 } }, { "accn": "0001628280-25-009774", "filed": "2025-03-04", "fiscal_year": 2022, "form": "10-K", "fundamental_units": { "cash": "USD", "cost_of_revenue": "USD", "eps_diluted": "USD/shares", "gross_profit": "USD", "net_income": "USD", "operating_cash_flow": "USD", "operating_income": "USD", "revenue": "USD", "stockholders_equity": "USD", "total_assets": "USD", "total_liabilities": "USD" }, "fundamentals": { "cash": 20300000.0, "cost_of_revenue": 29253000.0, "eps_diluted": -0.24, "gross_profit": 42797000.0, "net_income": -16540000.0, "operating_cash_flow": -15098000.0, "operating_income": -18628000.0, "revenue": 72050000.0, "stockholders_equity": 28672000.0, "total_assets": 54057000.0, "total_liabilities": 25385000.0 }, "period_end": "2022-12-31", "ratio_units": { "gross_margin": "ratio", "leverage": "ratio", "net_margin": "ratio", "operating_margin": "ratio", "revenue_growth_yoy": "ratio", "roa_avg2y": "ratio", "roa_period_end": "ratio", "roe_avg2y": "ratio", "roe_period_end": "ratio" }, "ratios": { "gross_margin": 0.5939902845246356, "leverage": 0.8853585379464286, "net_margin": -0.22956280360860515, "operating_margin": -0.25854267869535047, "revenue_growth_yoy": 0.06821450280953016, "roa_avg2y": -0.2956290159700439, "roa_period_end": -0.30597332445381725, "roe_avg2y": -0.5476911869401812, "roe_period_end": -0.5768694196428571 } }, { "accn": "0001628280-24-009380", "filed": "2024-03-06", "fiscal_year": 2021, "form": "10-K", "fundamental_units": { "cash": "USD", "cost_of_revenue": "USD", "eps_diluted": "USD/shares", "gross_profit": "USD", "net_income": "USD", "operating_cash_flow": "USD", "operating_income": "USD", "revenue": "USD", "stockholders_equity": "USD", "total_assets": "USD", "total_liabilities": "USD" }, "fundamentals": { "cash": 28219000.0, "cost_of_revenue": 25959000.0, "eps_diluted": -0.4, "gross_profit": 41490000.0, "net_income": -27128000.0, "operating_cash_flow": -24163000.0, "operating_income": -27073000.0, "revenue": 67449000.0, "stockholders_equity": 31727000.0, "total_assets": 57840000.0, "total_liabilities": 26113000.0 }, "period_end": "2021-12-31", "ratio_units": { "gross_margin": "ratio", "leverage": "ratio", "net_margin": "ratio", "operating_margin": "ratio", "revenue_growth_yoy": "ratio", "roa_avg2y": "ratio", "roa_period_end": "ratio", "roe_avg2y": "ratio", "roe_period_end": "ratio" }, "ratios": { "gross_margin": 0.6151314326379932, "leverage": 0.8230529202256753, "net_margin": -0.4022001808774036, "operating_margin": -0.40138474995922846, "revenue_growth_yoy": 0.13824527060094166, "roa_avg2y": -0.564003409634296, "roa_period_end": -0.46901798063623784, "roe_avg2y": -1.1267886440572366, "roe_period_end": -0.8550445992372427 } }, { "accn": "0001628280-23-006968", "filed": "2023-03-08", "fiscal_year": 2020, "form": "10-K", "fundamental_units": { "cash": "USD", "cost_of_revenue": "USD", "eps_diluted": "USD/shares", "gross_profit": "USD", "net_income": "USD", "operating_cash_flow": "USD", "operating_income": "USD", "revenue": "USD", "stockholders_equity": "USD", "total_assets": "USD", "total_liabilities": "USD" }, "fundamentals": { "cash": 16697000.0, "cost_of_revenue": 23983000.0, "eps_diluted": -0.33, "gross_profit": 35274000.0, "net_income": -19925000.0, "operating_cash_flow": -10600000.0, "operating_income": -19854000.0, "revenue": 59257000.0, "stockholders_equity": 16424000.0, "total_assets": 38358000.0, "total_liabilities": 21934000.0 }, "period_end": "2020-12-31", "ratio_units": { "gross_margin": "ratio", "leverage": "ratio", "net_margin": "ratio", "operating_margin": "ratio", "revenue_growth_yoy": "ratio", "roa_avg2y": "ratio", "roa_period_end": "ratio", "roe_avg2y": "ratio", "roe_period_end": "ratio" }, "ratios": { "gross_margin": 0.5952714447238301, "leverage": 1.3354846566000975, "net_margin": -0.3362471944242874, "operating_margin": -0.3350490237440302, "revenue_growth_yoy": 0.2800976431703787, "roa_avg2y": -0.506965205775714, "roa_period_end": -0.5194483549715835, "roe_avg2y": -1.080853833844151, "roe_period_end": -1.2131636629322942 } }, { "accn": "0001654954-21-002692", "filed": "2022-03-14", "fiscal_year": 2019, "form": "10-K", "fundamental_units": { "cash": "USD", "cost_of_revenue": "USD", "gross_profit": "USD", "net_income": "USD", "operating_cash_flow": "USD", "operating_income": "USD", "revenue": "USD", "stockholders_equity": "USD", "total_assets": "USD", "total_liabilities": "USD" }, "fundamentals": { "cash": 18812000.0, "cost_of_revenue": 20522000.0, "gross_profit": 25769000.0, "net_income": -32147000.0, "operating_cash_flow": -20439000.0, "operating_income": -31300000.0, "revenue": 46291000.0, "stockholders_equity": 20445000.0, "total_assets": 40247000.0, "total_liabilities": 19802000.0 }, "period_end": "2019-12-31", "ratio_units": { "gross_margin": "ratio", "leverage": "ratio", "net_margin": "ratio", "operating_margin": "ratio", "revenue_growth_yoy": "ratio", "roa_avg2y": "ratio", "roa_period_end": "ratio", "roe_avg2y": "ratio", "roe_period_end": "ratio" }, "ratios": { "gross_margin": 0.5566740835151541, "leverage": 0.9685497676693569, "net_margin": -0.694454645611458, "operating_margin": -0.6761573524011147, "revenue_growth_yoy": 0.4669011629749342, "roa_avg2y": -0.7795196353011069, "roa_period_end": -0.798742763435784, "roe_avg2y": -1.3500619448585767, "roe_period_end": -1.5723648813890927 } }, { "accn": "0001654954-21-002692", "filed": "2021-03-12", "fiscal_year": 2018, "form": "10-K", "fundamental_units": { "buybacks": "USD", "cost_of_revenue": "USD", "gross_profit": "USD", "net_income": "USD", "operating_cash_flow": "USD", "operating_income": "USD", "revenue": "USD", "stockholders_equity": "USD", "total_assets": "USD", "total_liabilities": "USD" }, "fundamentals": { "buybacks": 404000.0, "cost_of_revenue": 15502000.0, "gross_profit": 16055000.0, "net_income": -33316000.0, "operating_cash_flow": -20908000.0, "operating_income": -33172000.0, "revenue": 31557000.0, "stockholders_equity": 27178000.0, "total_assets": 42232000.0, "total_liabilities": 15054000.0 }, "period_end": "2018-12-31", "ratio_units": { "gross_margin": "ratio", "leverage": "ratio", "net_margin": "ratio", "operating_margin": "ratio", "revenue_growth_yoy": "ratio", "roa_avg2y": "ratio", "roa_period_end": "ratio", "roe_avg2y": "ratio", "roe_period_end": "ratio" }, "ratios": { "gross_margin": 0.5087619228697278, "leverage": 0.5539038928545147, "net_margin": -1.0557404062490097, "operating_margin": -1.0511772348448838, "revenue_growth_yoy": 0.4884675251167398, "roa_avg2y": -0.6348565112999733, "roa_period_end": -0.7888804697859443, "roe_avg2y": -0.8224954327753913, "roe_period_end": -1.2258444329972773 } }, { "accn": "0001654954-20-002437", "filed": "2020-03-10", "fiscal_year": 2017, "form": "10-K", "fundamental_units": { "buybacks": "USD", "cost_of_revenue": "USD", "gross_profit": "USD", "net_income": "USD", "operating_cash_flow": "USD", "operating_income": "USD", "revenue": "USD", "stockholders_equity": "USD", "total_assets": "USD", "total_liabilities": "USD" }, "fundamentals": { "buybacks": 0.0, "cost_of_revenue": 10724000.0, "gross_profit": 10477000.0, "net_income": -11378000.0, "operating_cash_flow": -9804000.0, "operating_income": -16377000.0, "revenue": 21201000.0, "stockholders_equity": 53834000.0, "total_assets": 62724000.0, "total_liabilities": 8890000.0 }, "period_end": "2017-12-30", "ratio_units": { "gross_margin": "ratio", "leverage": "ratio", "net_margin": "ratio", "operating_margin": "ratio", "roa_avg2y": "ratio", "roa_period_end": "ratio", "roe_avg2y": "ratio", "roe_period_end": "ratio" }, "ratios": { "gross_margin": 0.49417480307532663, "leverage": 0.16513727384181, "net_margin": -0.5366727984529032, "operating_margin": -0.7724635630394794, "roa_avg2y": -0.27591034043960483, "roa_period_end": -0.18139787003379887, "roe_avg2y": -0.35663239719157475, "roe_period_end": -0.21135341977189134 } }, { "accn": "0001654954-19-002395", "filed": "2019-03-07", "fiscal_year": 2016, "form": "10-K", "fundamental_units": { "gross_profit": "USD", "net_income": "USD", "operating_cash_flow": "USD", "operating_income": "USD", "stockholders_equity": "USD", "total_assets": "USD", "total_liabilities": "USD" }, "fundamentals": { "gross_profit": 10390534.0, "net_income": -2928185.0, "operating_cash_flow": -2936596.0, "operating_income": -2905210.0, "stockholders_equity": 9974000.0, "total_assets": 19752068.0, "total_liabilities": 9777710.0 }, "period_end": "2016-12-31", "ratio_units": { "leverage": "ratio", "roa_period_end": "ratio", "roe_period_end": "ratio" }, "ratios": { "leverage": 0.9803198315620614, "roa_period_end": -0.14824700887015982, "roe_period_end": -0.29358181271305395 } }, { "accn": "0001415889-14-000961", "filed": "2014-03-27", "fiscal_year": 2012, "form": "10-K", "fundamental_units": { "buybacks": "USD" }, "fundamentals": { "buybacks": 8200.0 }, "period_end": "2012-12-29", "ratios": {} }, { "accn": "0001415889-12-000348", "filed": "2012-03-15", "fiscal_year": 2011, "form": "10-K", "fundamental_units": { "eps_diluted": "USD/shares" }, "fundamentals": { "eps_diluted": -0.12 }, "period_end": "2011-12-31", "ratios": {} } ], "latest_filing": { "accn": "0001386570-26-000013", "filed": "2026-03-04", "form": "10-K" }, "note": "Static grepcent export of verified SEC companyfacts-derived values. Monetary values are raw reported units from grepcent's resolved facts; no scaling and no FX conversion. Capex, dividends, and buybacks are reported as positive outflow magnitudes. ROE/ROA include both period-end basis (site-consistent) and average-of-two-years basis where the prior-year denominator exists.", "schema_version": "1", "sic": "2833", "sic_description": "Medicinal Chemicals & Botanical Products", "source_urls": { "sec_companyfacts": "https://data.sec.gov/api/xbrl/companyfacts/CIK0001386570.json", "sec_submissions": "https://data.sec.gov/submissions/CIK0001386570.json" }, "ticker": "NAGE" }